Advances in targeted therapy for acute myeloid leukemia

Acute myeloid leukemia (AML) is a clonal malignancy characterized by genetic heterogeneity due to recurrent gene mutations. Treatment with cytotoxic chemotherapy has been the standard of care for more than half of a century. Although much progress has been made toward improving treatment related mor...

Full description

Saved in:
Bibliographic Details
Published in:Biomark Res
Main Authors: Yu, Jifeng, Jiang, Peter Y. Z., Sun, Hao, Zhang, Xia, Jiang, Zhongxing, Li, Yingmei, Song, Yongping
Format: Artigo
Language:Inglês
Published: BioMed Central 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238648/
https://ncbi.nlm.nih.gov/pubmed/32477567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00196-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items